This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sagard Capital Partners Completes Acquisition Of IntegraMed® America

Sagard Capital Partners, L.P. (“Sagard Capital”) and IntegraMed America, Inc. (NASDAQ: INMD) (“IntegraMed”), a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced the completion of Sagard Capital’s acquisition of IntegraMed for $14.05 per share in cash, representing a total equity purchase price of approximately $169.5 million. As a result of the transaction’s completion, IntegraMed’s common stock will cease trading at the close of market today and will be delisted from the NASDAQ Global Market.

Dan Friedberg, Managing Partner of Sagard Capital, said, “We are thrilled to partner with IntegraMed and its impressive team of medical, clinical and administrative personnel. Over the past 25 years, they have built an enviable reputation for providing the highest levels of service to health care facilities that allow for superior patient care, treatment innovation and treatment financing solutions. Sagard is committed to providing IntegraMed’s physician practices, clinics and management with the resources necessary to deliver world-class patient care, to retain and grow top quality partners, and to develop complementary business opportunities. We see a significant opportunity to extend the reach of IntegraMed’s business, bringing its medical specialties to a growing base of patients across the U.S. We look forward to working with the IntegraMed team to support them in building upon their industry leading position and in achieving continued success.”

Jay Higham, CEO and President of IntegraMed, commented, “This is an exciting day for IntegraMed, our patients, physicians and staff as we begin our new partnership with Sagard Capital. As a private company and with the full strategic and financial support of Sagard, IntegraMed is now uniquely positioned to expand the reach of the patient communities we serve. We will also be able to invest aggressively in supporting our physicians and clinic staff to improve the quality of patient care. At the same time, we will continue to explore ways to leverage the IntegraMed model into new areas of specialty and to drive further efficiency into our operations while also bringing innovation to the solutions we provide.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs